ArticleFrontiers in drug discovery2025

Towards human cardiac new approach methodologies (NAMs) to evaluate the combination of repolarization prolonging and shortening drugs: a pilot study.

Robert M Geiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.